UNITED STATES SECURITIES AND EXCHANGE COMMISSION | ||
Washington, D.C. 20549 |
Delaware | 001-34666 | 14-1896129 | ||||||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common stock | MXL | The Nasdaq Stock Market LLC |
Exhibit | Description | ||||
99.1 | |||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Date: | January 29, 2025 | MAXLINEAR, INC. | ||||||||||||
(Registrant) | ||||||||||||||
By: | /s/ Steven G. Litchfield | |||||||||||||
Steven G. Litchfield | ||||||||||||||
Chief Financial Officer and Chief Corporate Strategy Officer | ||||||||||||||
(Principal Financial Officer) | ||||||||||||||
Fiscal Year 2024 Financial Highlights | |||||
• |
Net revenue was $360.5 million, down 48.0% over fiscal 2023. |
||||
• |
GAAP gross margin was 54.0%, down from 55.6% in the prior year, and non-GAAP gross margin was 59.7%, down from 60.8% the prior year. |
||||
• |
GAAP operating expenses were $418.1 million, or 116% of net revenue, compared to $423.9 million or 61% of net revenue in fiscal 2023, and non-GAAP operating expenses were $283.7 million, or 79% of net revenue, compared to $314.1 million or 45% of net revenue in the prior year. |
||||
• |
GAAP loss from operations was 62% of net revenue, compared to GAAP loss from operations of 6% in fiscal 2023, and non-GAAP loss from operations was 19% of net revenue, compared to non-GAAP income from operations of 16% in the prior year. |
||||
• |
Net cash flow used in operations of $45.3 million, compared to net cash flow provided by operations of $43.4 million in fiscal 2023. |
||||
• |
GAAP diluted loss per share was $2.93 compared to GAAP diluted loss per share of $0.91 in the prior year, while non-GAAP diluted loss per share was $0.90 compared to non-GAAP diluted earnings per share of $1.10 in fiscal 2023. |
Three Months Ended | |||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | |||||||||||||||
Net revenue | $ | 92,167 | $ | 81,102 | $ | 125,353 | |||||||||||
Cost of net revenue | 40,919 | 37,022 | 56,814 | ||||||||||||||
Gross profit | 51,248 | 44,080 | 68,539 | ||||||||||||||
Operating expenses: | |||||||||||||||||
Research and development | 51,278 | 52,604 | 65,250 | ||||||||||||||
Selling, general and administrative | 38,087 | 30,154 | 34,384 | ||||||||||||||
Impairment losses | — | 1,237 | — | ||||||||||||||
Restructuring charges | 3,056 | 26,828 | 10,648 | ||||||||||||||
Total operating expenses | 92,421 | 110,823 | 110,282 | ||||||||||||||
Loss from operations | (41,173) | (66,743) | (41,743) | ||||||||||||||
Interest income | 1,040 | 1,653 | 1,781 | ||||||||||||||
Interest expense | (2,802) | (2,655) | (2,909) | ||||||||||||||
Other income (expense), net | 2,113 | (14,753) | 240 | ||||||||||||||
Total other income (expense), net | 351 | (15,755) | (888) | ||||||||||||||
Loss before income taxes | (40,822) | (82,498) | (42,631) | ||||||||||||||
Income tax provision (benefit) | 17,016 | (6,713) | (4,131) | ||||||||||||||
Net loss | $ | (57,838) | $ | (75,785) | $ | (38,500) | |||||||||||
Net loss per share: | |||||||||||||||||
Basic | $ | (0.68) | $ | (0.90) | $ | (0.47) | |||||||||||
Diluted | $ | (0.68) | $ | (0.90) | $ | (0.47) | |||||||||||
Shares used to compute net loss per share: | |||||||||||||||||
Basic | 84,485 | 84,074 | 81,681 | ||||||||||||||
Diluted | 84,485 | 84,074 | 81,681 |
Twelve Months Ended | ||||||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||||
Net revenue | $ | 360,528 | $ | 693,263 | ||||||||||
Cost of net revenue | 165,746 | 307,600 | ||||||||||||
Gross profit | 194,782 | 385,663 | ||||||||||||
Operating expenses: | ||||||||||||||
Research and development | 225,189 | 269,504 | ||||||||||||
Selling, general and administrative | 138,329 | 132,156 | ||||||||||||
Impairment losses | 1,237 | 2,438 | ||||||||||||
Restructuring charges | 53,379 | 19,786 | ||||||||||||
Total operating expenses | 418,134 | 423,884 | ||||||||||||
Loss from operations | (223,352) | (38,221) | ||||||||||||
Interest income | 6,386 | 6,053 | ||||||||||||
Interest expense | (10,874) | (10,702) | ||||||||||||
Other income (expense), net | (10,877) | (20,940) | ||||||||||||
Total other income (expense), net | (15,365) | (25,589) | ||||||||||||
Loss before income taxes | (238,717) | (63,810) | ||||||||||||
Income tax provision | 6,481 | 9,337 | ||||||||||||
Net loss | $ | (245,198) | $ | (73,147) | ||||||||||
Net loss per share: | ||||||||||||||
Basic | $ | (2.93) | $ | (0.91) | ||||||||||
Diluted | $ | (2.93) | $ | (0.91) | ||||||||||
Shares used to compute net loss per share: | ||||||||||||||
Basic | 83,600 | 80,719 | ||||||||||||
Diluted | 83,600 | 80,719 | ||||||||||||
Three Months Ended | |||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | |||||||||||||||
Operating Activities | |||||||||||||||||
Net loss | $ | (57,838) | $ | (75,785) | $ | (38,500) | |||||||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||||
Amortization and depreciation | 11,714 | 12,142 | 16,593 | ||||||||||||||
Impairment of intangible assets | — | 1,237 | — | ||||||||||||||
Impairment of investments and other assets | — | 14,000 | — | ||||||||||||||
Amortization of debt issuance costs and accretion of discount on debt and leases | 548 | 637 | 703 | ||||||||||||||
Stock-based compensation | 18,813 | 12,788 | 16,413 | ||||||||||||||
Deferred income taxes | 13,884 | (8,320) | (10,954) | ||||||||||||||
Loss on disposal of property and equipment | — | 623 | — | ||||||||||||||
Gain on sale of investments | — | — | (434) | ||||||||||||||
Unrealized holding gain on investments | — | — | (2,152) | ||||||||||||||
Impairment of leased right-of-use assets | 2,140 | 677 | — | ||||||||||||||
Gain on extinguishment of lease liabilities | (1) | (1) | — | ||||||||||||||
(Gain) loss on foreign currency and other | (2,226) | 2,339 | 2,335 | ||||||||||||||
Excess tax deficiencies on stock based awards | 262 | 1,469 | 276 | ||||||||||||||
Changes in operating assets and liabilities: | |||||||||||||||||
Accounts receivable, net | (37,534) | 37,010 | (12,363) | ||||||||||||||
Inventory | 5,720 | (1,325) | 15,034 | ||||||||||||||
Prepaid expenses and other assets | 6,742 | (7,852) | 887 | ||||||||||||||
Accounts payable, accrued expenses and other current liabilities | 17,448 | (6,708) | (11,514) | ||||||||||||||
Accrued compensation | (2,092) | 159 | 932 | ||||||||||||||
Accrued price protection liability | (1,071) | (17,158) | 3,474 | ||||||||||||||
Lease liabilities | (2,889) | (2,761) | (2,780) | ||||||||||||||
Other long-term liabilities | (1,458) | 6,098 | 5,477 | ||||||||||||||
Net cash used in operating activities | (27,838) | (30,731) | (16,573) | ||||||||||||||
Investing Activities | |||||||||||||||||
Purchases of property and equipment | (2,193) | (4,132) | (1,274) | ||||||||||||||
Purchases of intangible assets | (805) | (1,818) | (157) | ||||||||||||||
Cash used in acquisitions, net of cash acquired | — | — | (940) | ||||||||||||||
Sales of trading securities | — | — | 17,198 | ||||||||||||||
Net cash provided by (used in) investing activities | (2,998) | (5,950) | 14,827 | ||||||||||||||
Financing Activities | |||||||||||||||||
Net proceeds from issuance of common stock | 2,512 | — | 1,391 | ||||||||||||||
Minimum tax withholding paid on behalf of employees for restricted stock units | (1,091) | (58) | (220) | ||||||||||||||
Net cash provided by (used in) financing activities | 1,421 | (58) | 1,171 | ||||||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (474) | 94 | 779 | ||||||||||||||
Increase (decrease) in cash, cash equivalents and restricted cash | (29,889) | (36,645) | 204 | ||||||||||||||
Cash, cash equivalents and restricted cash at beginning of period | 149,492 | 186,137 | 188,152 | ||||||||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 119,603 | $ | 149,492 | $ | 188,356 | |||||||||||
Year Ended | ||||||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||||
Operating Activities | ||||||||||||||
Net loss | $ | (245,198) | $ | (73,147) | ||||||||||
Adjustments to reconcile net loss to cash provided by (used in) operating activities: | ||||||||||||||
Amortization and depreciation | 54,140 | 71,516 | ||||||||||||
Impairment of intangible assets | 1,237 | 2,438 | ||||||||||||
Impairment of investments and other assets | 14,000 | — | ||||||||||||
Amortization of debt issuance costs and accretion of discount on debt and leases | 2,538 | 2,561 | ||||||||||||
Stock-based compensation | 66,021 | 55,176 | ||||||||||||
Deferred income taxes | 826 | (4,452) | ||||||||||||
Loss on disposal of property and equipment | 1,068 | 2,057 | ||||||||||||
Gain on sale of investments | — | (434) | ||||||||||||
Unrealized holding loss on investments | — | 1,765 | ||||||||||||
Impairment of leased right-of-use assets | 5,555 | — | ||||||||||||
Gain on settlement of pension | — | (1,008) | ||||||||||||
Gain on extinguishment of lease liabilities | (555) | — | ||||||||||||
(Gain) loss on foreign currency | (1,253) | 2,475 | ||||||||||||
Excess tax (benefits) deficiencies on stock based awards | 3,250 | (253) | ||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||
Accounts receivable, net | 85,155 | 1,406 | ||||||||||||
Inventory | 9,565 | 60,636 | ||||||||||||
Prepaid expenses and other assets | (1,873) | (9,328) | ||||||||||||
Accounts payable, accrued expenses and other current liabilities | (4,569) | (29,431) | ||||||||||||
Accrued compensation | 919 | 9,708 | ||||||||||||
Accrued price protection liability | (28,283) | (41,562) | ||||||||||||
Lease liabilities | (10,695) | (11,671) | ||||||||||||
Other long-term liabilities | 2,857 | 4,920 | ||||||||||||
Net cash provided by (used in) operating activities | (45,295) | 43,372 | ||||||||||||
Investing Activities | ||||||||||||||
Purchases of property and equipment | (17,680) | (13,454) | ||||||||||||
Purchases of intangible assets | (5,766) | (6,355) | ||||||||||||
Cash used in acquisitions, net of cash acquired | — | (13,324) | ||||||||||||
Sales of trading securities | — | 17,198 | ||||||||||||
Net cash used in investing activities | (23,446) | (15,935) | ||||||||||||
Financing Activities | ||||||||||||||
Payment of debt commitment fees | — | (18,325) | ||||||||||||
Net proceeds from issuance of common stock | 4,091 | 4,559 | ||||||||||||
Minimum tax withholding paid on behalf of employees for restricted stock units |
(2,805) | (12,590) | ||||||||||||
Net cash provided by (used in) financing activities | 1,286 | (26,356) | ||||||||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | (1,298) | (1,082) | ||||||||||||
Decrease in cash, cash equivalents and restricted cash | (68,753) | (1) | ||||||||||||
Cash, cash equivalents and restricted cash at beginning of period | 188,356 | 188,357 | ||||||||||||
Cash, cash equivalents and restricted cash at end of period | $ | 119,603 | $ | 188,356 | ||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | |||||||||||||||
Assets | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash and cash equivalents | $ | 118,575 | $ | 148,476 | $ | 187,288 | |||||||||||
Short-term restricted cash | 1,003 | 993 | 1,051 | ||||||||||||||
Accounts receivable, net | 85,464 | 47,930 | 170,619 | ||||||||||||||
Inventory | 90,343 | 96,063 | 99,908 | ||||||||||||||
Prepaid expenses and other current assets | 28,057 | 34,798 | 29,159 | ||||||||||||||
Total current assets | 323,442 | 328,260 | 488,025 | ||||||||||||||
Long-term restricted cash | 25 | 23 | 17 | ||||||||||||||
Property and equipment, net | 59,300 | 63,493 | 66,431 | ||||||||||||||
Leased right-of-use assets | 18,184 | 22,549 | 31,264 | ||||||||||||||
Intangible assets, net | 55,008 | 58,031 | 73,630 | ||||||||||||||
Goodwill | 318,588 | 318,588 | 318,588 | ||||||||||||||
Deferred tax assets | 68,662 | 82,552 | 69,493 | ||||||||||||||
Other long-term assets | 21,430 | 21,807 | 32,809 | ||||||||||||||
Total assets | $ | 864,639 | $ | 895,303 | $ | 1,080,257 | |||||||||||
Liabilities and stockholders’ equity | |||||||||||||||||
Current liabilities | $ | 182,284 | $ | 168,597 | $ | 222,129 | |||||||||||
Long-term lease liabilities | 16,952 | 19,433 | 26,243 | ||||||||||||||
Long-term debt | 122,996 | 122,840 | 122,375 | ||||||||||||||
Other long-term liabilities | 26,124 | 27,561 | 23,245 | ||||||||||||||
Stockholders’ equity | 516,283 | 556,872 | 686,265 | ||||||||||||||
Total liabilities and stockholders’ equity | $ | 864,639 | $ | 895,303 | $ | 1,080,257 |
Three Months Ended | |||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | |||||||||||||||
GAAP gross profit | $ | 51,248 | $ | 44,080 | $ | 68,539 | |||||||||||
Stock-based compensation | 186 | 81 | 137 | ||||||||||||||
Performance based equity | 8 | (19) | 17 | ||||||||||||||
Amortization of purchased intangible assets | 2,990 | 3,498 | 8,332 | ||||||||||||||
Non-GAAP gross profit | 54,432 | 47,640 | 77,025 | ||||||||||||||
GAAP R&D expenses | 51,278 | 52,604 | 65,250 | ||||||||||||||
Stock-based compensation | (10,862) | (7,423) | (11,061) | ||||||||||||||
Performance based equity | (743) | 775 | (1,918) | ||||||||||||||
Research and development funded by others | — | 3,000 | (2,000) | ||||||||||||||
Non-GAAP R&D expenses | 39,673 | 48,956 | 50,271 | ||||||||||||||
GAAP SG&A expenses | 38,087 | 30,154 | 34,384 | ||||||||||||||
Stock-based compensation | (7,766) | (5,284) | (5,215) | ||||||||||||||
Performance based equity | (811) | 384 | (1,324) | ||||||||||||||
Amortization of purchased intangible assets | (592) | (591) | (591) | ||||||||||||||
Acquisition and integration costs | (7,261) | (801) | (1,799) | ||||||||||||||
Non-GAAP SG&A expenses | 21,657 | 23,862 | 25,455 | ||||||||||||||
GAAP impairment losses | — | 1,237 | — | ||||||||||||||
Impairment losses | — | (1,237) | — | ||||||||||||||
Non-GAAP impairment losses | — | — | — | ||||||||||||||
GAAP restructuring expenses | 3,056 | 26,828 | 10,648 | ||||||||||||||
Restructuring charges | (3,056) | (26,828) | (10,648) | ||||||||||||||
Non-GAAP restructuring expenses | — | — | — | ||||||||||||||
GAAP loss from operations | (41,173) | (66,743) | (41,743) | ||||||||||||||
Total non-GAAP adjustments | 34,275 | 41,565 | 43,042 | ||||||||||||||
Non-GAAP income (loss) from operations | (6,898) | (25,178) | 1,299 | ||||||||||||||
GAAP interest and other income (expense), net | 351 | (15,755) | (888) | ||||||||||||||
Non-recurring interest and other income (expense), net | 326 | 11,769 | 54 | ||||||||||||||
Non-GAAP interest and other income (expense), net | 677 | (3,986) | (834) | ||||||||||||||
GAAP loss before income taxes | (40,822) | (82,498) | (42,631) | ||||||||||||||
Total non-GAAP adjustments | 34,601 | 53,334 | 43,096 | ||||||||||||||
Non-GAAP income (loss) before income taxes | (6,221) | (29,164) | 465 | ||||||||||||||
GAAP income tax provision (benefit) | 17,016 | (6,713) | (4,131) | ||||||||||||||
Adjustment for non-cash tax benefits/expenses | (16,016) | 7,568 | 4,177 | ||||||||||||||
Non-GAAP income tax provision | 1,000 | 855 | 46 | ||||||||||||||
GAAP net loss | (57,838) | (75,785) | (38,500) | ||||||||||||||
Total non-GAAP adjustments before income taxes | 34,601 | 53,334 | 43,096 | ||||||||||||||
Less: total tax adjustments | (16,016) | 7,568 | 4,177 | ||||||||||||||
Non-GAAP net income (loss) | $ | (7,221) | $ | (30,019) | $ | 419 | |||||||||||
Shares used in computing GAAP and non-GAAP basic net income (loss) per share | 84,485 | 84,074 | 81,681 | ||||||||||||||
Shares used in computing GAAP diluted net loss per share | 84,485 | 84,074 | 81,681 | ||||||||||||||
Dilutive common stock equivalents | — | — | 1,000 | ||||||||||||||
Shares used in computing non-GAAP diluted net income (loss) per share | 84,485 | 84,074 | 82,681 | ||||||||||||||
Non-GAAP basic net income (loss) per share | $ | (0.09) | $ | (0.36) | $ | 0.01 | |||||||||||
Non-GAAP diluted net income (loss) per share | $ | (0.09) | $ | (0.36) | $ | 0.01 |
Year ended | ||||||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||||
GAAP gross profit | $ | 194,782 | $ | 385,663 | ||||||||||
Stock-based compensation | 621 | 763 | ||||||||||||
Performance based equity | 24 | 111 | ||||||||||||
Amortization of purchased intangible assets | 19,798 | 35,102 | ||||||||||||
Non-GAAP gross profit | 215,225 | 421,639 | ||||||||||||
GAAP R&D expenses | 225,189 | 269,504 | ||||||||||||
Stock-based compensation | (38,814) | (44,189) | ||||||||||||
Performance based equity | (3,108) | (7,568) | ||||||||||||
Research and development funded by others | 2,000 | (9,500) | ||||||||||||
Non-GAAP R&D expenses | 185,267 | 208,247 | ||||||||||||
GAAP SG&A expenses | 138,329 | 132,156 | ||||||||||||
Stock-based compensation | (26,586) | (10,224) | ||||||||||||
Performance based equity | (2,132) | (3,874) | ||||||||||||
Amortization of purchased intangible assets | (2,366) | (2,881) | ||||||||||||
Acquisition and integration costs | (8,828) | (9,286) | ||||||||||||
Non-GAAP SG&A expenses | 98,417 | 105,891 | ||||||||||||
GAAP impairment losses | 1,237 | 2,438 | ||||||||||||
Impairment losses | (1,237) | (2,438) | ||||||||||||
Non-GAAP impairment losses | — | — | ||||||||||||
GAAP restructuring expenses | 53,379 | 19,786 | ||||||||||||
Restructuring charges | (53,379) | (19,786) | ||||||||||||
Non-GAAP restructuring expenses | — | — | ||||||||||||
GAAP loss from operations | (223,352) | (38,221) | ||||||||||||
Total non-GAAP adjustments | 154,893 | 145,722 | ||||||||||||
Non-GAAP income (loss) from operations | (68,459) | 107,501 | ||||||||||||
GAAP interest and other income (expense), net | (15,365) | (25,589) | ||||||||||||
Non-recurring interest and other income (expense), net | 12,233 | 18,628 | ||||||||||||
Non-GAAP interest and other income (expense), net | (3,132) | (6,961) | ||||||||||||
GAAP loss before income taxes | (238,717) | (63,810) | ||||||||||||
Total non-GAAP adjustments | 167,126 | 164,350 | ||||||||||||
Non-GAAP income (loss) before income taxes | (71,591) | 100,540 | ||||||||||||
GAAP income tax provision | 6,481 | 9,337 | ||||||||||||
Adjustment for non-cash tax benefits/expenses | (2,481) | 717 | ||||||||||||
Non-GAAP income tax provision | 4,000 | 10,054 | ||||||||||||
GAAP net loss | (245,198) | (73,147) | ||||||||||||
Total non-GAAP adjustments before income taxes | 167,126 | 164,350 | ||||||||||||
Less: total tax adjustments | (2,481) | 717 | ||||||||||||
Non-GAAP net income (loss) | $ | (75,591) | $ | 90,486 | ||||||||||
Shares used in computing GAAP and non-GAAP basic net income (loss) per share | 83,600 | 80,719 | ||||||||||||
Shares used in computing GAAP diluted net loss per share | 83,600 | 80,719 | ||||||||||||
Dilutive common stock equivalents | — | 1,210 | ||||||||||||
Shares used in computing non-GAAP diluted net income (loss) per share | 83,600 | 81,929 | ||||||||||||
Non-GAAP basic net income (loss) per share | $ | (0.90) | $ | 1.12 | ||||||||||
Non-GAAP diluted net income (loss) per share | $ | (0.90) | $ | 1.10 | ||||||||||
Three Months Ended | |||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | |||||||||||||||
GAAP gross margin | 55.6 | % | 54.4 | % | 54.7 | % | |||||||||||
Stock-based compensation | 0.2 | % | 0.1 | % | 0.1 | % | |||||||||||
Performance based equity | — | % | — | % | — | % | |||||||||||
Amortization of purchased intangible assets | 3.2 | % | 4.3 | % | 6.7 | % | |||||||||||
Non-GAAP gross margin | 59.1 | % | 58.7 | % | 61.4 | % | |||||||||||
GAAP R&D expenses | 55.6 | % | 64.9 | % | 52.1 | % | |||||||||||
Stock-based compensation | (11.8) | % | (9.2) | % | (8.8) | % | |||||||||||
Performance based equity | (0.8) | % | 1.0 | % | (1.5) | % | |||||||||||
Research and development funded by others | — | % | 3.7 | % | (1.6) | % | |||||||||||
Non-GAAP R&D expenses | 43.0 | % | 60.4 | % | 40.1 | % | |||||||||||
GAAP SG&A expenses | 41.3 | % | 37.2 | % | 27.4 | % | |||||||||||
Stock-based compensation | (8.4) | % | (6.5) | % | (4.2) | % | |||||||||||
Performance based equity | (0.9) | % | 0.5 | % | (1.1) | % | |||||||||||
Amortization of purchased intangible assets | (0.6) | % | (0.7) | % | (0.5) | % | |||||||||||
Acquisition and integration costs | (7.9) | % | (1.0) | % | (1.4) | % | |||||||||||
Non-GAAP SG&A expenses | 23.5 | % | 29.4 | % | 20.3 | % | |||||||||||
GAAP impairment losses | — | % | 1.5 | % | — | % | |||||||||||
Impairment losses | — | % | (1.5) | % | — | % | |||||||||||
Non-GAAP impairment losses | — | % | — | % | — | % | |||||||||||
GAAP restructuring expenses | 3.3 | % | 33.1 | % | 8.5 | % | |||||||||||
Restructuring charges | (3.3) | % | (33.1) | % | (8.5) | % | |||||||||||
Non-GAAP restructuring expenses | — | % | — | % | — | % | |||||||||||
GAAP loss from operations | (44.7) | % | (82.3) | % | (33.3) | % | |||||||||||
Total non-GAAP adjustments | 37.2 | % | 51.3 | % | 34.3 | % | |||||||||||
Non-GAAP income (loss) from operations | (7.5) | % | (31.0) | % | 1.0 | % | |||||||||||
GAAP interest and other income (expense), net | 0.4 | % | (19.4) | % | (0.7) | % | |||||||||||
Non-recurring interest and other income (expense), net | 0.4 | % | 14.5 | % | — | % | |||||||||||
Non-GAAP interest and other income (expense), net | 0.7 | % | (4.9) | % | (0.7) | % | |||||||||||
GAAP loss before income taxes | (44.3) | % | (101.7) | % | (34.0) | % | |||||||||||
Total non-GAAP adjustments before income taxes | 37.5 | % | 65.8 | % | 34.4 | % | |||||||||||
Non-GAAP income (loss) before income taxes | (6.8) | % | (36.0) | % | 0.4 | % | |||||||||||
GAAP income tax provision (benefit) | 18.5 | % | (8.3) | % | (3.3) | % | |||||||||||
Adjustment for non-cash tax benefits/expenses | (17.4) | % | 9.3 | % | 3.3 | % | |||||||||||
Non-GAAP income tax provision | 1.1 | % | 1.1 | % | — | % | |||||||||||
GAAP net loss | (62.8) | % | (93.4) | % | (30.7) | % | |||||||||||
Total non-GAAP adjustments before income taxes | 37.5 | % | 65.8 | % | 34.4 | % | |||||||||||
Less: total tax adjustments | (17.4) | % | 9.3 | % | 3.3 | % | |||||||||||
Non-GAAP net income (loss) | (7.8) | % | (37.0) | % | 0.3 | % |
Year ended | ||||||||||||||
December 31, 2024 | December 31, 2023 | |||||||||||||
GAAP gross margin | 54.0 | % | 55.6 | % | ||||||||||
Stock-based compensation | 0.2 | % | 0.1 | % | ||||||||||
Performance based equity | — | % | — | % | ||||||||||
Amortization of purchased intangible assets | 5.5 | % | 5.1 | % | ||||||||||
Non-GAAP gross margin | 59.7 | % | 60.8 | % | ||||||||||
GAAP R&D expenses | 62.5 | % | 38.9 | % | ||||||||||
Stock-based compensation | (10.8) | % | (6.4) | % | ||||||||||
Performance based equity | (0.9) | % | (1.1) | % | ||||||||||
Research and development funded by others | 0.6 | % | (1.4) | % | ||||||||||
Non-GAAP R&D expenses | 51.4 | % | 30.0 | % | ||||||||||
GAAP SG&A expenses | 38.4 | % | 19.1 | % | ||||||||||
Stock-based compensation | (7.4) | % | (1.5) | % | ||||||||||
Performance based equity | (0.6) | % | (0.6) | % | ||||||||||
Amortization of purchased intangible assets | (0.7) | % | (0.4) | % | ||||||||||
Acquisition and integration costs | (2.5) | % | (1.3) | % | ||||||||||
Non-GAAP SG&A expenses | 27.3 | % | 15.3 | % | ||||||||||
GAAP impairment losses | 0.3 | % | 0.4 | % | ||||||||||
Impairment losses | (0.3) | % | (0.4) | % | ||||||||||
Non-GAAP impairment losses | — | % | — | % | ||||||||||
GAAP restructuring expenses | 14.8 | % | 2.9 | % | ||||||||||
Restructuring charges | (14.8) | % | (2.9) | % | ||||||||||
Non-GAAP restructuring expenses | — | % | — | % | ||||||||||
GAAP loss from operations | (62.0) | % | (5.5) | % | ||||||||||
Total non-GAAP adjustments | 43.0 | % | 21.0 | % | ||||||||||
Non-GAAP income (loss) from operations | (19.0) | % | 15.5 | % | ||||||||||
GAAP interest and other income (expense), net | (4.3) | % | (3.7) | % | ||||||||||
Non-recurring interest and other income (expense), net | 3.4 | % | 2.7 | % | ||||||||||
Non-GAAP interest and other income (expense), net | (0.9) | % | (1.0) | % | ||||||||||
GAAP loss before income taxes | (66.2) | % | (9.2) | % | ||||||||||
Total non-GAAP adjustments | 46.4 | % | 23.7 | % | ||||||||||
Non-GAAP income (loss) before income taxes | (19.9) | % | 14.5 | % | ||||||||||
GAAP income tax provision | 1.8 | % | 1.4 | % | ||||||||||
Adjustment for non-cash tax benefits/expenses | (0.7) | % | 0.1 | % | ||||||||||
Non-GAAP income tax provision | 1.1 | % | 1.5 | % | ||||||||||
GAAP net loss | (68.0) | % | (10.6) | % | ||||||||||
Total non-GAAP adjustments before income taxes | 46.4 | % | 23.7 | % | ||||||||||
Less: total tax adjustments | (0.7) | % | 0.1 | % | ||||||||||
Non-GAAP net income (loss) | (21.0) | % | 13.1 | % | ||||||||||